Vol. 24, No. 1, January 2001
Diabetes, Hypertension, and Cardiovascular Disease
C. R. Conti, M.D., M.A.C.C. 1
Right Ventricular Involvement in Hypertrophic Cardiomyopathy: A Case Report and Literature Review [Full text: HTML | PDF]
D. Mozaffarian, M.D., and J. H. Caldwell, M.D. 2
A. Onat, M.D., M.S., FESC, V. Sansoy, M.D., FESC, B. Yildirim, M.D. 9
Significance of Circulatory Epinephrine Levels in Exercise-Induced Neurally Mediated Syncope
B. Takase, M.D., FACC, S. Kastushika, M.D., A. Hamabe, M.D., A. Uehata, M.D., K. Isojima, M.D., K. Satomura, M.D., T. Nishioka, M.D., F. Ohsuzu, M.D., FACC, A. Kurita, M.D., FACC 15
B. A. Samad, M.D., Ph.D., K. Jensen-Urstad, M.D., Ph.D., J. Hulting, M.D., Ph.D., H. Ruiz, M.D., J. Höjer, M.D., Ph.D., F. Bouvier, M.D., Ph.D., M. Jensen-Urstad, M.D., Ph.D. 21
R. A. Archbold, MRCP, K. Barakat, M.A., MRCP, P. Magee, FRCS, N. Curzen, Ph.D., MRCP 26
M. Kosuge, M.D., K. Kimura, M.D., T. Ishikawa, M.D., T. Endo, M.D., T. Shigemasa, M.D., M. Sugiyama, M.D., O. Tochikubo, M.D., S. Umemura, M.D. 33
Influence of Age on Left Atrial Appendage Function in Patients with Nonvalvular Atrial Fibrillation
A. Ilercil, M.D., J. Kondapaneni, M.D., A. Hla, M.D., J. Shirani, M.D. 39
S. K. Dwivedi, D.M., R. K. Saran, D.M., S. Mittal, D.M., R. Gupta, D.M., V. S. Narain, D.M., V. K. Puri, D.M., FRCP 45
M. C. K. Chui, D. E. Newby, B.A., B.Sc. (hons), B.M., D.M., MRCP, M. Panarelli, M.B., Ch.B., MRCP, P. Bloomfield, M.B., Ch.B., M.D., FRCP, N. A. Boon, M.B., Ch.B., M.D., FRCP 52
E. F. Philbin, M.D., FACC, P. A. McCullough, M.D., M.P.H., FACC, G. W. Dec, M.D., FACC, T. G. DiSalvo, M.D., M.Sci. 56
J. B. McGill, M.D., and P. A. Reilly, Ph.D. 66
Heart Rate-Lowering and -Regulating Effects of Once-Daily Sustained-Release Diltiazem
W. E. Boden, M.D., M. Vray, Ph.D., E. Eschwege, M.D., D. Lauret, B.Sc., R. Scheldewaert, M.D. 73
Homocysteine: A New Cardiac Risk Factor?
A. U. Chai, M.D., and J. Abrams, M.D. 80
TARGET (Do Tirofiban and Reopro Give Similiar Efficacy Outcomes Trial) 85
MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) 85
TACTICS (Treat Angina with Aggrastat + Determine Cost of Therapy with an Invasive or Conservative Strategy)--TIMI 18 86
Val-HeFT (Valsartan Heart Failure Trial) 86
AMIOVIRT (Amiodarone vs. Implantable Defibrillator in Patients with Non-Ischemic Cardiomyopathy and Asymptomatic Non-Sustained Ventricular Tachycardia) 87
C-PORT (Cardiovascular Patient Outcomes Research Team) 87
FLORIDA (Fluvastatin On Risk Diminishing after Acute Myocardial Infarction) 87
INHIBIT (Intimal Hyperplasia Inhibition with Beta In-stent Trial) 88
VMAC (Vasodilation in the Management of Acute CHF) 88
V. S. DeGeare, M.D., and R. D. Safian, M.D. 89
Single Left Coronary Artery with Origin of the Right Coronary Artery from Distal Circumflex
R. L. Shammas, M.D., FACC, M. J. Miller, M.D., FACC, FSCAI, J. D. Babb, M.D., FACC, FSCAI 90
W. B. Fye, M.D., M.A. 93